Lower Serum Triglyceride Levels Research Articles

Severe hypoglycemia with reduced liver volume as an indicator of end-stage malnutrition in patients with anorexia nervosa: a retrospective observational study

BackgroundHypophosphatemia due to excessive carbohydrate administration is considered the primary pathogenesis of refeeding syndrome. However, its association with liver injury and hypoglycemia, often seen in severe malnutrition before re-nutrition, remains unclear. Autophagy reportedly occurs in the liver of patients with severe malnutrition. This study aimed to clarify the pathophysiology of liver injury and hypoglycemia by focusing on liver volume.MethodsForty-eight patients with anorexia nervosa with a body mass index (BMI) of < 13 kg/m2 were included (median BMI: 10.51 kg/m2 on admission). Liver volume was measured in 36 patients who underwent abdominal computed tomography (CT), and the “estimated liver weight/ideal body weight” was used as the liver volume index. Seventeen blood test items were analyzed during the first 60 days.ResultsLiver volume significantly decreased when abdominal CTs were conducted shortly before or after hypoglycemia compared to when the scans were performed during periods without hypoglycemia. Five patients with severe hypoglycemia on days 13–18 after admission had a very low nutritional intake; of them, four showed a marked decrease in liver volume. Severe hypoglycemia was accompanied by low serum triglycerides and liver dysfunction. Patients experiencing hypoglycemia of blood glucose levels < 55 mg/dL (< 3.05 mmol/L) (32 patients; median lowest BMI: 9.45 kg/m2) exhibited significantly poorer blood findings for most of the 17 items, except serum phosphorus and potassium, than did those not experiencing hypoglycemia (16 patients; median lowest BMI: 11.2 kg/m2). All patients with a poor prognosis belonged to the hypoglycemia group. Empirically, initiating re-nutrition at 500 kcal/day (20–25 kcal/kg/day), increasing to 700–800 kcal/day after a week, and then gradually escalating can reduce serious complications following severe hypoglycemia.ConclusionsLiver volume reduction accompanied by hypoglycemia, low serum triglyceride levels, and liver dysfunction occurs when the body's stored energy sources are depleted and external nutritional intake is inadequate, suggesting that the liver was consumed as a last resort to obtain energy essential for daily survival. This pathophysiology, distinct from refeeding syndrome, indicates the terminal stage of malnutrition and is a risk factor for complications and poor prognosis. In treatment, extremely low nutrient levels should be avoided.

Comparison of the therapeutic effects of febuxostat combined with a low-purine diet and allopurinol combined with a low-purine diet on the improvement of gout patients.

To compare the clinical efficacy of febuxostat combined with a low-purine diet versus allopurinol combined with a low-purine diet in the treatment of gout. In this prospective controlled trial, 98 gout patients admitted to our hospital from February 2021 to December 2022 were enrolled as study subjects. Patients were randomly assigned to the study group (febuxostat combined with a low-purine diet) and the control group (allopurinol combined with a low-purine diet), with 49 patients in each group. The therapeutic effect was evaluated based on joint function and serum uric acid levels after treatment, and classified into three levels: markedly effective, effective, and ineffective. The levels of inflammatory factors, including tumor necrosis factor-a (TNF-a), cytokine interleukin-1beta (IL-1β), and interleukin (IL)-18 (IL-18), were collected. The Numeric Rating Scale (NRS) was used to assess the degree of pain in patients. Clinical indicators before and 6 months after treatment were compared between the two groups. There was no statistically significant difference in age and gender between the two groups. After 6 months of treatment, the effective rate in the study group (48 cases, 97.96%) was higher than that in the control group (42 cases, 85.71%), with a statistically significant difference (p = .027). At the same time, the study group had significantly lower levels of serum uric acid (162.39 μmol/L ± 17.23 μmol/L vs. S198.32 μmol/L ± 18.34 μmol/L, p < .001), creatinine (87.39 mmol/L ± 9.76 mmol/L vs. 92.18 mmol/L ± 9.27 mmol/L, p = .014), total cholesterol (3.65 mmol/L ± 0.65 mmol/L vs. 4.76 mmol/L ± 0.73 mmol/L, p < .001), and triglycerides (1.76 mmol/L ± 0.32 mmol/L vs. 2.28 mmol/L ± 0.41 mmol/L, p < .001) compared to the control group, with statistically significant differences (p < .05). After treatment, the levels of inflammatory factors and degree of pain in the study group were significantly lower than those in the control group (all p < .05). During the treatment process, the incidence of adverse reactions in the study group (2 cases, 4.08%) was lower than that in the control group (9 cases, 18.37%), with a statistically significant difference (p = .025). Febuxostat combined with a low-purine diet can reduce inflammatory factors and alleviate the degree of pain in gout patients, significantly improving their clinical symptoms.

Lower total cholesterol and triglyceride levels in ankylosing spondylitis than non-inflammatory rheumatic disease controls in a 1978-98 study: a potential effect of increased physical energetics in manual occupations in the pre-2000 chronologic era.

No article on serum lipids in ankylosing spondylitis (AS) and control subjects has been reported from USA. The primary aim of this study was to determine if any difference occurred in serum lipid levels in AS and control rheumatic disorders in two time periods, 1978-98 and 2000-10. The secondary aim was to investigate variables associated with lipid levels and if a difference was found between AS and control disorders. The AS patients were compared to non-inflammatory rheumatic disorders (NIRDs) in 1978-98 and 2000-10 surveys and to rheumatoid arthritis (RA) in the 2000-10 survey. Patients were matched within 5 years of age, sex, and clinic or hospital source. In the 1978-98 survey, entry mean (SEM) serum cholesterol level [mg/dL] was highly (p<0.001) significantly lower in 69 AS [179.0 (4.8)] than 69 matched NIRD controls [208.0 (5.6)]. In 29 pairs of AS and NIRD subjects having manual labour occupations, mean (SEM) cholesterol level was additionally lower in AS [156.7 (5.9)] and higher in 29 NIRD controls [213.3 (8.6)] (p<0.001). In manual labour workers, mean (SEM) serum triglyceride was significantly lower (p=0.004) in 15 AS [110.3 (14.1)] than 14 NIRD controls [185.2 (19.3)]. In the 2000-10 survey, no lipid difference was found between AS vs. NIRD control patients. In the 1978-98 survey, AS had significantly lower mean serum cholesterol and triglyceride levels than NIRD control patients. Associated manual labour occupations may have significantly contributed to results, possibly related to increased energy expenditures from physical activity in the pre-2000 era.

Association of lipid levels with motor and cognitive function and decline in Parkinson's disease.

Most studies have focused on comparing blood lipid biomarkers between Parkinson's disease (PD) and normal controls (NC). However, further research is necessary to explore the impact of blood lipid levels on motor and cognitive function, as well as the progression of motor dysfunction and cognitive decline over time. Thus, the aim of this study is to investigate the relationship between blood lipid biomarkers and these indicators in individuals with PD. The cohort study enrolled 157 PD patients and 146 NC from the Tianjin Huanhu Hospital from September 2017 to September 2019. Serum lipid fractions were detected in fasting serum samples. PD patients were followed up at 2 ± 0.6 years for clinical assessment. PD patients exhibited lower serum triglyceride (TG) levels as compared to NC (P = 0.008). PD male patients exhibited lower serum lipoprotein cholesterol(LDL-C) and total cholesterol (TC) levels than female patients (LDL-C: P = 0.034; TC: P = 0.019). Serum TG levels correlated significantly with Unified PD Rating Scale III, Hoehn and Yahr stage and Montreal Cognitive Assessment scores in PD patients. Additionally, serum TG levels were associated with follow-up motor function decline and cognitive decline in adjusted regression models in PD patients. To summarise, the study findings suggest that decreased serum TG levels are significantly associated with greater motor dysfunction, cognitive dysfunction and the greater deterioration of the two indicators.

Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.

Transmembrane prolyl 4-hydroxylase (P4H-TM) is an enigmatic enzyme whose cellular function and primary substrate remain to be identified. Its loss-of-function mutations cause a severe neurological HIDEA syndrome with hypotonia, intellectual disability, dysautonomia and hypoventilation. Previously, P4H-TM deficiency in mice was associated with reduced atherogenesis and lower serum triglyceride levels. Here, we characterized the glucose and lipid metabolism of P4h-tm-/- mice in physiological and tissue analyses. P4h-tm-/- mice showed variations in 24-h oscillations of energy expenditure, VO2 and VCO2 and locomotor activity compared to wild-type (WT) mice. Their rearing activity was reduced, and they showed significant muscle weakness and compromised coordination. Sedated P4h-tm-/- mice had better glucose tolerance, lower fasting insulin levels, higher fasting lactate levels and lower fasting free fatty acid levels compared to WT. These alterations were not present in conscious P4h-tm-/- mice. Fasted P4h-tm-/- mice presented with faster hepatic glycogenolysis. The respiratory rate of conscious P4h-tm-/- mice was significantly lower compared to the WT, the decrease being further exacerbated by sedation and associated with acidosis and a reduced ventilatory response to both hypoxia and hypercapnia. P4H-TM deficiency in mice is associated with alterations in whole-body energy metabolism, day-night rhythm of activity, glucose homeostasis and neuromuscular and respiratory functions. Although the underlying mechanism(s) are not yet fully understood, the phenotype appears to have neurological origins, controlled by brain and central nervous system circuits. The phenotype of P4h-tm-/- mice recapitulates some of the symptoms of HIDEA patients, making this mouse model a valuable tool to study and develop tailored therapies.

Medicinal herbs consumption in relation to cardiometabolic indices and coronary artery stenosis in participants undergoing coronary angiography: A cross-sectional study.

Few studies have investigated the association between herbal medicine consumption and coronary artery disease severity. This cross-sectional study aimed to investigate the association between the frequency of medicinal herbs consumption and coronary artery stenosis (CAS), lipid profile, fasting blood sugar (FBS), and blood pressure level in participants undergoing coronary angiography. This study was conducted on 662 participants aged 35-75 years. Serum cardiometabolic markers were measured using standard kits. The extent and severity of CAS were evaluated using the Gensini score (GS) and syntax score (SS). Higher consumption of Thymus vulgaris and Sumac was associated with decreased odds of artery-clogging according to the GS. A higher intake of Thymus vulgaris and Mentha was associated with lower levels of serum cholesterol and triglyceride. Monthly intake of Thymus vulgaris, and weekly/daily intake of Mentha, Nigella Sativa, and Cuminum Cyminum were associated with lower low-density lipoprotein. Weekly/daily intake of Turmeric and Thymus vulgaris were associated with lower high-density lipoprotein levels and monthly intake of Mentha was related to lower serum FBS levels. Higher consumption of Mentha, Mentha pulegium L, Lavandula angustifolia, and Nigella Sativa was associated with lower levels of systolic blood pressure. According to the results of the present study, herbs consumption might be related to a reduction in CAS risk factors.

Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes.

Hepatic ketogenesis is a key metabolic pathway that regulates energy homeostasis. Some related controversies exist regarding the pathogenesis of metabolic-associated fatty liver disease (MAFLD). We aimed to investigate whether intact ketogenic capacity could reduce the risk of MAFLD based on transient electrography (TE) in patients with newly diagnosed type 2 diabetes (T2D). A total of 361 subjects with newly diagnosed T2D were recruited and classified into two groups based on the median serum β-hydroxybutyrate (βHB) level, referred to as the intact and impaired ketogenesis groups. The glucometabolic relevance of ketogenic capacity and associations of the baseline serum β-HB and MAFLD assessed with TE were investigated. Compared to the impaired ketogenesis group, the intact ketogenesis group showed better insulin sensitivity, lower serum triglyceride levels, and higher glycated hemoglobin levels. The controlled attenuation parameter (CAP) was lower in the intact ketogenesis group without statistical significance (289.7 ± 52.1 vs. 294.5 ± 43.6; p=0.342) but the prevalence of moderate-severe steatosis defined by CAP ≥260 dB/m was significantly lower in the intact group. Moreover, intact ketogenesis was significantly associated with a lower risk of moderate-severe MAFLD after adjusting for potential confounders (adjusted odds ratio 0.55, 95% confidence interval 0.30-0.98; p=0.044). In drug-naïve, newly diagnosed T2D patients, intact ketogenesis predicted a lower risk of moderate-severe MAFLD assessed by TE.

In situ visualization of the cellular uptake and sub-cellular distribution of mussel oligosaccharides

Unlike chemosynthetic drugs designed for specific molecular and disease targets, active small-molecule natural products typically have a wide range of bioactivities and multiple targets, necessitating extensive screening and development. To address this issue, we propose a strategy for the direct in situ microdynamic examination of potential drug candidates to rapidly identify their effects and mechanisms of action. As a proof-of-concept, we investigated the behavior of mussel oligosaccharide (MOS-1) by tracking the subcellular dynamics of fluorescently labeled MOS-1 in cultured cells. We recorded the entire dynamic process of the localization of fluorescein isothiocyanate (FITC)-MOS-1 to the lysosomes and visualized the distribution of the drug within the cell. Remarkably, lysosomes containing FITC-MOS-1 actively recruited lipid droplets, leading to fusion events and increased cellular lipid consumption. These drug behaviors confirmed MOS-1 is a candidate for the treatment of lipid-related diseases. Furthermore, in a high-fat HepG2 cell model and in high-fat diet-fed apolipoprotein E (ApoE)−/− mice, MOS-1 significantly promoted triglyceride degradation, reduced lipid droplet accumulation, lowered serum triglyceride levels, and mitigated liver damage and steatosis. Overall, our work supports the prioritization of in situ visual monitoring of drug location and distribution in subcellular compartments during the drug development phase, as this methodology contributes to the rapid identification of drug indications. Collectively, this methodology is significant for the screening and development of selective small-molecule drugs, and is expected to expedite the identification of candidate molecules with medicinal effects.

Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial.

Pemafibrate, a selective peroxisome proliferator-activated receptor α modulator that lowers serum triglyceride levels and increases high-density lipoprotein cholesterol levels, is approved for treating dyslipidemia as twice-daily immediate-release (IR) tablets. A once-daily extended-release (XR) tablet has also been developed. We aimed to confirm the non-inferiority of XR (0.2 or 0.4 mg/day; once daily) to IR (0.2 mg/day; twice daily) in lowering triglyceride levels in patients with hypertriglyceridemia. This phase 3, multicenter, randomized, double-blind study included patients with fasting triglycerides ≥ 200 mg/dL who received IR (0.2 mg/day) or XR (0.2 or 0.4 mg/day). The primary efficacy endpoint was the percentage change in fasting triglyceride levels from baseline to 4, 8, and 12 weeks. Common treatment effects at weeks 4 through 12 were compared between groups using repeated analysis of covariance. In 356 randomized patients, fasting triglyceride levels decreased by 48.0%, 43.8%, and 48.0% with IR 0.2, XR 0.2, and XR 0.4 mg/day, respectively, confirming the non-inferiority of both XR regimens to IR. The proportion of patients who achieved fasting triglycerides ＜150 mg/dL was 45.7%, 37.4%, and 51.7%, while the percentage change of triglycerides in the subgroup with baseline triglycerides ≥ 500 mg/dL was -59.3%, -52.2%, and -66.3% with IR 0.2, XR 0.2, and XR 0.4 mg/day, respectively. XR (0.2 and 0.4 mg/day) was non-inferior to IR (0.2 mg/day). XR 0.4 mg/day demonstrated a more potent triglyceride-lowering effect than XR 0.2 mg/day and should be considered for patients with high triglyceride levels.

Influence of ultrasound on Pleurotus pulmonarius (Fr.) Quél. (Grey Oyster Mushroom) – Protective Effects Against Metabolic Syndrome in Rats Fed with a High-fat Diet

The Pleurotus pulmonarius (Fr.) Quel. (Grey Oyster mushroom) is one of the most widely consumed mushroom species worldwide, and it possesses various medicinal properties. The application of ultrasound resulted in P. pulmonarius extracts with improved bioactivities both in cellular and animal models. However, no studies have investigated the preventive effects of ultrasound extract of P. pulmonarius in animal models. In this study, Wistar-Kyoto rats were pre-treated with the ultrasound extract of P. pulmonarius at high (500 mg/kg bw) and low (200 mg/kg bw) doses for 15 days. The rats were subsequently fed with a high-fat diet (HFD) for another 15 days. Rats pre-treated with P. pulmonarius extract from a high-dose ultrasound showed lower levels of serum cholesterol (1.50 mmol/L), triglyceride (0.60 mmol/L), and LDL (0.29 mmol/L). These rats also had lower oxidative stress, with MDA levels of only 10.81 µg/mg protein. The ultrasound extract of P. pulmonarius also exhibited anti-hyperglycaemic effects, whereby rats had lower blood glucose levels. Rats pre-treated with the ultrasound extract of P. pulmonarius also had inhibited inflammatory biomarkers CREB1 (2.85 pmol/mL), NF-κB2 (0.81 ng/mL), and STAT3 (0.48 ng/mL), proving the anti-inflammatory activity of the ultrasound extract. This study is the first to show the ability of P. pulmonarius extract prepared using ultrasound to prevent developing metabolic syndrome such as hyperlipidaemia, hyperglycaemia, oxidative stress, and inflammation in rats fed with HFD.

Effects of Different Stress Applications on Some Reproductive Hormones, Sperm Parameters, Lipid Profile, Immunohistochemical and Immunofluorescent Markers

The current study assessed how 5 stress protocols applied affected sperm parameters, lipid profile, and some reproductive hormones. Live materials of the study consisted of 50 rats. The number of rats in the groups was equal and they were randomly assigned. Each group consisted of 10 rats. No stress application was conducted in the control group. The rats in the psychological stress group were subjected to a cycle of 4-hour light and 20-hour dark per day. The rats in the physical stress group were deprived of feed and water for two hours per day. In the psychological stress + physical stress group, the psychological and physical stress protocol was conducted. In the first 4 groups, all the applications were conducted for 14 days. A different stress application was applied to the rats in the depression group every day. It was determined that the abnormal sperm rate was high in the stress and depression groups, but the highest rate was in the depression group. In addition, sperm motility and sperm concentration were the lowest in the depression group. While the stress and depression groups had significantly lower serum triglyceride and HDL levels and LH and FSH levels, cholesterol and LDL values were significantly higher. Bax expression and 8 OHdG expression were severe in psychological stress+physical stress group and depression group. When the findings are evaluated collectively; it was determined that stress negatively affected sperm parameters, lipid profile, reproductive hormones, immunofluorescence and immunohistochemical parameters.

Effects of Season, Productive State, Age and Agro-ecology on Blood Biochemical Characteristics of Dromedary Camels (Camelus dromedarius) in Natural Browsing Environment

Background: Blood biochemistry and reference intervals assist in distinguishing between healthy and productive camels as well as providing information for nutritional conditions, evaluation and monitoring when they are allowed to browse naturally; nevertheless, these intervals are frequently collected from animals of varying ages. The nutritional condition and biochemical markers of dromedary camels in pastoral systems in southern Ethiopia were investigated in this study, which took season, animal status, age and environmental variables into consideration. Methods: A total of 36 camels were divided into three groups based on their age ( greater than 8 years, 5-8 years, or less than 5 years) and productive state (milking, pregnant and young) in two environments (two herds in arid and semi-arid areas). Blood samples were collected from animals’ neck jugular veins, centrifuged and frozen for analysis. The samples were centrifuged (3000 rpm for 10 min) immediately after their arrival at the laboratory. Serum concentrations of glucose, protein, urea, creatinine, triglycerides and cholesterol were measured using spectrophotometry. Result: This study shows that glucose (91.33+7.30 mg/dl), total protein (7.17+0.15 mg/dl) and triglyceride (75.28+5.38 mg/dl) concentrations were significantly higher (P less than 0.05) during the rainy season, whereas urea (32.06+1.18 mg/l) and creatinine levels were significantly higher during the dry season. The study reveals increased glucose, total protein and triglyceride concentrations in camels during the rainy season, while urea and creatinine levels were higher during the dry season. Arid camels had lower serum concentrations of total protein and urea. Milking and pregnant camels had lower total serum protein, triglyceride and cholesterol levels.

Association between Serum Triglycerides and Severity of Stroke

Abstract Background: The purpose of the present research was to study the correlation between serum triglyceride (TG) levels and the severity of stroke as limited data are available on the role of TGs. The severity of stroke was determined using the Scandinavian Stroke Scale (SSS). Methods: In this cross-sectional study, 60 patients with acute ischemic stroke were included, who were diagnosed on clinical examination and 3-dimensional magnetic resonance imaging scan of the brain. Serum TG levels were categorized according to the National Cholesterol Education Program and the Adult Treatment Panel. Stroke severity was assessed with the help of SSS. Results: The mean serum TG levels in the study were found to be 147.7 mg/dl ± 92 mg/dl. The mean SSS score in the study was 27.93 ± 3.86. There was a statistically significant association between the serum TG levels and SSS (P = 0.001). The association was suggested by a positive Pearson correlation coefficient (r = 0.481). Patients with low serum TG levels (≤150 mg/dl) had severe strokes as assessed by the SSS (≤25). Conclusion: This study confirms that low levels of TG are associated with poor outcome of acute ischemic stroke, which can be explained by the fact that low serum TG levels indicate malnutrition, which is a poor prognostic factor.

Phytochemistry, Ethnobotanical uses and Pharmacology of Borago officinalis Linn: A Review

The plant Borage (Borago officinalis L.) family-Boraginaceae, also known as "starflower" is an annual herb originating in Syria, but naturalized throughout the Mediterranean region, as well as Asia Minor, Europe, North Africa, and South America. Aims of the Review The purpose of this study is to provide comprehensive scientific information on the phytochemistry, traditional uses and pharmacological activities of Borago officinalis L. The plant is reputed as hepatoprotective, gastrointestinal, respiratory anxiolytic, antispasmodic, antihypertensive, antipyretic, aphrodisiac, demulcent, diuretic and is also considered useful to treat asthma, bronchitis, cramps, palpitations and kidney ailments. Borage oil has been reported to lower serum cholesterol, phospholipids and triglyceride levels and increases the levels of 6 polyunsaturated fatty acids in the plasma, liver, aorta and renal artery tissues and ω -3 polyunsaturated fatty acids (PUFAs) obtained from Borago officinalis L. Dietary use of borage oil exhibited immuno -modulatory, cytotoxic and free radical scavenging activities. Borage has gained importance, due to the occurrence of high levels of g-linolenic acid in its seed oil. Flavonoids and phenolic compounds were the important essential oils in this plant and no have tannin. Borago officinalis extracts demonstrated excellent antioxidant properties and these effects were attributed to their phenolic constituents. Few studies examining Iron, Copper, Zinc and Manganese fertility in Borage have been conducted, but they are not specific to the medicinal use of this plant.

Rare Variant in Metallothionein 1E Increases the Risk of Type 2 Diabetes in a Chinese Population.

To uncover novel targets for the treatment of type 2 diabetes (T2D) by investigating rare variants with large effects in monogenic forms of the disease. We performed whole-exome sequencing in a family with diabetes. We validated the identified gene using Sanger sequencing in additional families and diabetes- and community-based cohorts. Wild-type and variant gene transgenic mouse models were used to study the gene function. Our analysis revealed a rare variant of the metallothionein 1E (MT1E) gene, p.C36Y, in a three-generation family with diabetes. This risk allele was associated with T2D or prediabetes in a community-based cohort. MT1E p.C36 carriers had higher HbA1c levels and greater BMI than those carrying the wild-type allele. Mice with forced expression of MT1E p.C36Y demonstrated increased weight gain, elevated postchallenge serum glucose and liver enzyme levels, and hepatic steatosis, similar to the phenotypes observed in human carriers of MT1E p.C36Y. In contrast, mice with forced expression of MT1E p.C36C displayed reduced weight and lower serum glucose and serum triglyceride levels. Forced expression of wild-type and variant MT1E demonstrated differential expression of genes related to lipid metabolism. Our results suggest that MT1E could be a promising target for drug development, because forced expression of MT1E p.C36C stabilized glucose metabolism and reduced body weight, whereas MT1E p.C36Y expression had the opposite effect. These findings highlight the importance of considering the impact of rare variants in the development of new T2D treatments.

Distribution of cerebral age-related white matter changes in relation to risk factors in stroke patients

IntroductionThe distribution of cerebral age-related white matter changes (ARWMC) may be indicative of the underlying etiology and could suggest optimal interventions. We aimed to determine if left ventricular hypertrophy (LVH), a marker of uncontrolled hypertension, along with additional risk factors are associated with the distribution of cerebral ARWMC. MethodsWe analyzed data of 172 patients from a hospital stroke registry who had acute stroke and brain MRI. We classified lesion location as superficial (frontal, parieto-occipital, or temporal) or deep (basal nuclei) using the ARWMC scale. We defined a superficial ARWMC index as the superficial minus the deep score. We excluded infratentorial lesions and patients with bilateral strokes. Regression analysis analyzed LVH and other relevant clinical factors for independent association with the superficial ARWMC index. ResultsThe superficial ARWMC scores ranged from 0 to 6, the deep scores from 0 to 3, and the superficial ARWMC index from −2 to 6. We categorized the superficial ARWMC index as −2 to 1 (n = 65), 2 (n = 50), and 3 – 6 (n = 57). In bivariate analysis, ARWMC distribution was significantly associated with older age, lower household income (HI), and lower serum triglyceride (TG) levels. In multiple logistic regression analysis, higher superficial ARWMC index was significantly associated with lower HI (OR 10.72, 95 % CI 2.30–49.85), lower serum low density cholesterol (LDL) (OR 0.86, 95 % CI 0.75–0.98, per 10 mg/dL), and lower serum TG levels (OR 0.91, 95 % CI 0.85–0.99, per 10 mg/dL). The area under the curve in receiver operating characteristic analysis (95 % CI) for HI was 0.63 (0.49–0.76), LDL level 0.64 (0.51–0.77), and TG level 0.77 (0.65–0.88). ConclusionIn this study, LVH was not associated with the distribution of cerebral ARWMC. Using an alternate classification of ARWMC distribution and analyzing additional risk factors in larger studies may yield further discoveries.

Evaluation of dietary supplementation of frankincense oil on broiler chicken growth performance, hepatic histomorphology, antioxidant activity, blood biochemical parameters, and inflammatory responses

This investigation aimed to assess the potential impact of frankincense oil (FKO) from Boswellia serrata on broiler chicken growth performance parameters, including body weight (BW), body weight gain (BWG), feed intake (FI), and feed conversion ratio (FCR) during the starter, grower, and finisher phases. We also evaluated the hepatic histology, serum hepatorenal function tests, antioxidant activity, and inflammatory responses. A total of 400 three-day-old male chicks (Ross 308 broiler) (100.40 ± 0.13 g) were randomly assigned to four treatment groups (10 replicates/group, ten chicks/replicate). The birds were fed basal diet (FKO0, control group) or basal diet supplemented with 200, 400, and 600 FKO/kg of diet (FKO200, FKO400, FKO600, respectively). The experiment lasted 35 days. Gas chromatography-mass spectrometry analysis revealed that FKO contained 36 constituents, with the dominant compounds being 1,6,10-DODECATRIEN-3-OL, 3,7,11-TRIMETHYL-, [S-(Z)]- (12.42%), ç-Elemene (12.42%), à-Farnesene (12.42%), PHENOL and 2,4-BIS(1,1-DIMETHYLETHYL)- (7.15%). Distinctive FKO levels (200-600 mg/kg) showed greater BW without influencing total feed intake compared to the FKO0 treatment. The FCR was improved by the addition of FKO to the diets. The blood concentrations of alanine aminotransferase and creatinine increased (p < 0.05) in the FKO600 treatment. Dietary FKO linearly lowered serum malondialdehyde levels and enhanced blood total antioxidant capacity, catalase, superoxide dismutase, and pro-inflammatory cytokines (interleukine-1 β and interferon γ) compared to the control group. Broilers fed FKO at levels 200–600 mg kg−1 diet also exhibited lower serum total cholesterol, triglyceride, and low-density lipoprotein cholesterol levels. Furthermore, the FKO400 and FKO600 treatments showed an increase in high-density lipoprotein cholesterol (p < 0.01). Histomorphological analysis of the liver indicated no significant differences between the FKO-supplemented groups and the control group. However, the immunoexpression of the pro-inflammatory cytokine (transforming growth factor β) was considerably increased in the liver and spleen tissues of birds fed FKO in a level-dependent manner. In conclusion, dietary supplementation of FKO at levels up to 600 mg/kg can serve as a natural growth promoter in broiler chickens, leading to enhanced growth, hypolipidemic properties, antioxidant status, and immune responses.

Extension Region Domain of Soybean 7S Globulin Contributes to Serum Triglyceride-Lowering Effect via Modulation of Bile Acids Homeostasis.

Soybean 7S globulin (β-conglycinin), a major soybean storage protein, has been demonstrated to exert remarkable triglyceride (TG) and cholesterol-lowering effects, yet the underlying mechanism remains controversial. A comparative investigation is performed to assess the contribution of different structural domains of soybean 7S globulin, including core region (CR) and extension region (ER) domains, to biological effects of soybean 7S globulin using a high-fat diet rat model. The results show that ER domain mainly contributes to the serum TG-lowering effect of soybean 7S globulin, but not for CR domain. Metabolomics analysis reveals that oral administration of ER peptides obviously influences the metabolic profiling of serum bile acids (BAs), as well as significantly increased the fecal excretion of total BAs. Meanwhile, ER peptides supplementation reshapes the composition of gut microbiota and impacts the gut microbiota-dependent biotransformation of BAs which indicate by a significantly increased secondary BAs concentration in fecal samples. These results highlight that TG-lowering effects of ER peptides mainly stem from their modulation of BAs homeostasis. Oral administration of ER peptides can effectively lower serum TG level by regulating BAs metabolism. ER peptides have potential to be used as a candidate pharmaceutical for the intervention of dyslipidemia.

Lower serum insulin-like growth factor-1 levels are independently associated with anemia in patients undergoing maintenance hemodialysis

The relationship between serum insulin-like growth factor-1 (IGF-1) levels and anemia in patients undergoing maintenance hemodialysis (MHD) remains unclear. This cross-sectional study included patients who underwent MHD treatment for >3 months at our dialysis center in March 2021. Demographic and clinical data were recorded. Blood samples were collected before the hemodialysis sessions, and general serum biochemical parameters, routine blood markers, and serum IGF-1 levels were measured. Patients were divided into a group without anemia (hemoglobin ≥110 g/L) and a group with anemia (hemoglobin <110 g/L), and multivariable linear and binary logistic regression analyses were performed to study the relationship between the levels of serum IGF-1 and anemia. A total of 165 patients (male/female = 99:66) with MHD were enrolled in the study, with a median age of 66.0 (58.0, 75.0) years and a median dialysis vintage of 27.0 (12.0, 55.0) months. The mean hemoglobin level was 96.38 ± 16.72 g/L, and 126 patients had anemia (76.4%). Compared to patients without anemia, patients with anemia had lower serum IGF-1 and triglyceride levels and higher intravenous iron supplementation on dialysis (all p < 0.05). After adjusting for confounding factors in different models, the nine-model multivariate binary logistic regression analyses also confirmed that lower serum IGF-1 levels and serum IGF-1 < 197.03 ng/ml were both independently associated with anemia in patients undergoing MHD. However, further multicenter studies with larger sample sizes are required to confirm these findings.

Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei, L. casei 431 on High-Fat Diet-Induced Obese Rats.

Obesity is currently regarded as a global concern, and the key objectives of the global health strategy include its prevention and control. Probiotic supplementation can help achieve these objectives. This study aimed to assess whether a probiotic strain Lactobacillus paracasei ssp. paracasei, Lactobacillus casei 431 (henceforth, L. casei 431) possesses antiobesogenic properties. High-fat diet-induced obese Sprague-Dawley rats were treated with L. casei 431 for 10 weeks, and the outcomes were compared with those of rats treated with the antiobesity medication orlistat. Body weights, epididymal fat, and tissues from mice were assessed. Furthermore, serological and histological analyses were performed. Epididymal fat accumulation was significantly reduced in groups administered L. casei 431 and orlistat. Furthermore, L. casei 431 and orlistat treatments lowered serum alanine transaminase, aspartate aminotransferase, and triglyceride (TG) levels. Hematoxylin and eosin staining of the liver and epididymal adipose tissues showed that the L. casei 431-treated groups exhibited reduced lipid buildup and adipocyte size. Furthermore, sterol regulatory element-binding protein 1c, adipose TG lipase, and lipoprotein lipase messenger RNA (mRNA) levels were upregulated, leading to lipid oxidation and degradation, in L. casei 431-supplemented groups. Furthermore, carnitine palmitoyltransferase 1, a major factor in lipolysis, was consistently upregulated at the protein level after L. casei 431 administration. Collectively, these results demonstrate the potential of L. casei 431 in alleviating obesity in rats through optimizing lipid metabolism and some related biomarkers.